|
Thursday, July 11, 2013 |
|
Get a Head Start in Growing Your Wealth at Invest Fair Malaysia |
ShareInvestor, the financial internet media and technology subsidiary of Singapore Press Holdings (SPH), will be hosting its signature Invest Fair events in Malaysia to encourage retail investors to grow their wealth through investing in diverse asset classes. more info >> |
|
Thursday, April 18, 2013 |
|
ShareInvestor to Launch New Financial Education Portal Targeted at Young Investors in Malaysia |
SI Portal.com Sdn Bhd, the subsidiary of ShareInvestor, the Singapore-based financial internet media and technology company, today launched a new portal targeted at educating tertiary students and young executives on the merits and importance of investing and financial planning. more info >> |
|
Thursday, March 2, 2023 |
|
SCIB Awarded RM20.65 million Project to Rebuild School |
Civil engineering specialist Sarawak Consolidated Industries Berhad (SCIB) today announced that the Group's wholly-owned subsidiary, SCIB Industrialised Building System Sdn. Bhd., has secured an engineering, procurement, construction, and commissioning (EPCC) contract from Jabatan Kerja Raya Sarawak (JKR) valued at RM20.65 million for the rebuilding of Sekolah Daif in Tebedu, Serian. more info >> |
|
Tuesday, February 28, 2023 |
|
Leon Fuat Records Revenue of RM1.03 Billion for the FY2022 |
LEON FUAT BERHAD, a manufacturer and trader of steel products specialising in rolled long and flat steel, today announced that the Group reported a 15.6% increase in revenue to RM1.03 billion for the financial year ended 31 December 2022 (FY2022) compared with RM886.58 million recorded for the preceding financial year (FY2021). more info >> |
|
Bintai Kinden Posts 9M Revenue of RM93.80 Million |
Bintai Kinden Corporation Berhad (Bursa: BINTAI, 6998), a mechanical and electrical (M&E) engineering services specialist, today announced that the Company recorded 60.8% gain in revenue to RM93.80 million for the nine months ended 31 December 2022 (9M FY2023) compared with RM58.34 million in the corresponding period of the last financial year (9M FY2022). more info >> |
|
Monday, February 27, 2023 |
|
SCIB Posts Higher Revenue of RM66 Million in 1H FY2023 |
Civil engineering specialist Sarawak Consolidated Industries Berhad (SCIB) today announced that the Group's revenue increased by 2.6% to RM66.3 million for the six months ended 31 December 2022 (1H FY2023) compared with RM64.6 million registered in the corresponding period of the previous financial year (1H FY2022). more info >> |
|
Malaysian Genomics to Boost Play on the Football Pitch |
Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, is collaborating with KL City FC Sdn Bhd (KLCFC), the manager of the KL City FC football club, on the deployment of the Group's genetic screening tests for peak athletic performance. more info >> |
|
PT Resources Signs MoU for an International Supply Chain Intelligent Park that Integrates Digital Technology |
PT Resources Holdings Berhad is pleased to announce that the Company has signed a memorandum of understanding (MoU) with Ocean Exchange (Fujian) Foreign Trade Services Co. Ltd to establish cooperation between the two parties for the joint development of the Malaysia East Coast International Supply Chain Intelligent Park, which is inspired by the Marche International Cold Logistics and Cross-border E-commerce Project (Fuzhou Park) located in Fujian province, China. more info >> |
|
Friday, February 24, 2023 |
|
Malaysian Genomics Pivots to Biopharmaceuticals for Growth |
Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, today announced that the Group recorded a revenue of RM1.64 million for the second quarter ended 31 December 2022 (2Q 2023). This amount is down from RM7.63 million in 2Q 2022, as the Group moved its focus from vaccines to biopharmaceuticals. more info >> |
|
Malaysian Genomics to Collaborate on Cannabinoid R&D |
Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, today announced that the Group has entered into a strategic collaboration with Kensana Health Canada and MAHSA University for the research and development (R&D) of phytopharmaceutical and biotechnology products that can lead to commercialisation. more info >> |
|
|
|